Ultra-Rapid Lispro: What is it and why is it interesting?
In the second article in this series looking at ultra-rapid insulin, we talk about Lilly’s new kid on the block: Ultra-Rapid Lispro (URLi) Ultra-Rapid Lispro […]
Blog Posts
“…Go faster. But don’t go stupid…” – A short series of articles on ultra-rapid insulins and closed loops
As we saw in a session at the EASD 2019 Conference, there are some interesting advances coming (or already here) in the realm of Ultra-Rapid […]
Libre Accuracy and Calibration using a third party transmitter – a case study
Abstract Introduction As a result of increased use of third party add-on transmitters to the Libre system to convert them into CGM, and the use […]
Adding to the options for MDI users – part two: Bringing it all together…
In the first part of this two parter we looked at what technology choices are available or coming to MDI users. In this part, we’ll […]
Adding to the options for MDI users – part one: What’s out there?
Over the last twelve months or so, connected devices have been the bywords for Diabetes treatment, and this isn’t just related to pumps and CGMs. […]
Blood test strips. Cost, quality, accuracy. What’s most important?
Following a recent tweet from Partha Kar, and the subsequent conversation it created on Twitter, I thought a deeper investigation into this topic was worthwhile. […]
If I could offer you only one tip for the future, sunscreen would be it – unless you wear CGM
A bit of Baz Luhrmann seemed an appropriate title, as his advice, “Wear sunscreen”, was obviously oblivious to the issues connected to sunscreen, swimming pools […]
Patching LibreLink for Libre2 – clearing the FUD
Last week, I posted a link to a github page on Facebook and Twitter, providing details of how to patch the LibreLink app on Android […]
Inside the Medtronic recall. What should we make of it?
As most people involved in WeAreNotWaiting are aware, on June 27th, the FDA issued a warning about cybersecurity issues with older medtronic pumps. These happen […]
Adding to the arsenal – what is the new oral add-on for Type 1 Diabetes?
For the first time, an oral add-on treatment, Dapagliflozin (aka Forxiga from Astra Zeneca) has received regulatory approval for managing type 1 diabetes. While this […]